Practical application of biobetters based on high-ADCC antibodies derived from genetically modified silkworms
A program to create antibodies with high ADCC activity by leveraging the glycan structures of genetically modified silkworms, with the aim of developing and commercializing them as biobetters.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.